Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Health Catalyst (HCAT) Shares Repurchased (2022 - 2025)

Health Catalyst posted quarterly Shares Repurchased of $5.0 million for Q1 2025, up 176.55% on a QoQ basis from $1.8 million in Q1 2023.

Health Catalyst (HCAT) has 3 years of Shares Repurchased data on file, last reported at $5.0 million in Q1 2025.

  • For the quarter ending Q1 2025, Shares Repurchased changed N/A year-over-year to $5.0 million; the trailing twelve-month figure through Dec 2025 stood at $5.0 million (changed N/A YoY), and the FY2025 full-year result was $5.0 million, changed N/A from the prior year.
  • Shares Repurchased for Q1 2025 stood at $5.0 million, up from $1.8 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $8.4 million in Q3 2022 and bottomed at $1.8 million in Q1 2023.
  • The 3-year median for Shares Repurchased is $5.0 million (2025), against an average of $5.1 million.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 60.00 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 123.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 104.97 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 90.53 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn -
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Health Catalyst 98.36 Mn -10.46 Mn 35.46 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 5.00 Mn
Mar 31, 2025 5.00 Mn
Mar 31, 2023 1.81 Mn
Mar 31, 2023 1.81 Mn
Sep 30, 2022 8.39 Mn
Sep 30, 2022 8.39 Mn